Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atracurium for facilitation of laryngeal mask airway insertion
IRCT20201207049639N4Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atracurium in None (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Number of attempts to successfully LMA insertion. Started May 2019; status: completed.
02
Drugs
atracurium
Beyond the preview
Go deeper on IRCT20201207049639N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201207049639N4.